Our case represents the first reported instance of Anti-Hu-associated PCD in a patient with adenocarcinoma of Müllerian origin and one of very few cases involving Anti-Zic4 antibodies in this malignancy (Kerasnoudis et al., 2011). Here, ZIC4 is linked to paraneoplastic neurologic syndrome.